THE MECHANISM OF ACTIVATION OF THE ALTERNATIVE PATHWAY OF COMPLEMENT BY CELL-BOUND C4B

被引:24
|
作者
FARRIES, TC
STEUER, KLK
ATKINSON, JP
机构
[1] WASHINGTON UNIV, SCH MED,DEPT MED,DIV RHEUMATOL,4566 SCOTT, BOX 8045, ST LOUIS, MO 63110 USA
[2] WASHINGTON UNIV, SCH MED, HOWARD HUGHES MED INST, MED LAB, ST LOUIS, MO 63110 USA
关键词
D O I
10.1016/0161-5890(90)90104-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Investigations into the mechanism of alternative pathway-dependent lysis of C4b-coated cells are reported. Test cells (EAC1q4b) were formed by reaction of sheep erythrocytes with antibody, C1 and C4. In C5-deficient serum, more C3b was deposited onto EAC1qC4b than onto control cells (EAC1q). The possibility that the C4bBb enzyme could form was considered, but no C3 convertase activity was generated when magnesium, properdin and factors B and D were added to EAC1qC4b. Binding studies employing radiolabeled components provided evidence that C4b bound the C3 convertase, C3bBbP, through a weak interaction with C3b. These data implied C3 conversion would be localized to the cell surface, thereby amplifying C3b deposition. This could be demonstrated in vitro. C3b, properdin, factor B and factor D were all required and the amplified C3b deposition was not due to deposition onto C4b itself. In serum, C5 convertase activity would be consequently expressed and cell lysis would result. This could be the mechanism by which the sera of C2-deficient patients mediate lysis of antibody coated sheep erythrocytes. © 1990.
引用
收藏
页码:1155 / 1161
页数:7
相关论文
共 50 条
  • [21] ACTIVATION OF THE ALTERNATIVE PATHWAY OF COMPLEMENT - A MECHANISM IN SEARCH OF DISEASES
    WILSON, MR
    SALVAGGIO, JE
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1980, 65 (05) : 319 - 321
  • [22] Complement C4A, C4B and BF haplotypes in Koreans
    Park, KS
    Park, MH
    Juji, T
    Tokunaga, K
    TISSUE ANTIGENS, 1996, 47 (03): : 200 - 205
  • [23] ACTIVATION OF THE CLASSICAL COMPLEMENT PATHWAY BY NEPHRITIC FACTOR BOUND TO THE ALTERNATIVE PATHWAY C3-C5 CONVERTASE
    SOBEL, AT
    COOPER, NR
    SCHREIBER, RD
    JOURNAL OF IMMUNOLOGY, 1979, 122 (01): : 34 - 38
  • [24] Cell-bound complement activation products as lupus biomarkers: diagnosis, monitoring and stratification
    Ahearn, Joseph M.
    Liu, Chau-Ching
    Manzi, Susan
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (12) : 1133 - 1142
  • [25] The Use of Cell-bound Complement Activation Product to Assess Disease Activity in SLE
    Rogers, Jennifer
    Eudy, Amanda
    Alexander, Roberta
    Pisetsky, David
    Conklin, John
    Sun, Kai
    Criscione-Schreiber, Lisa
    Doss, Jayanth
    Sadun, Rebecca
    Maheswaranathan, Mithu
    Clowse, Megan
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4159 - 4161
  • [26] Cell-bound Complement Activation Products in Combination with Low Complement C3 or C4 Have Superior Diagnostic Performance in Systemic Lupus Erythematosus
    Narain, Sonali
    Wallace, Daniel
    Putterman, Chaim
    Arriens, Cristina
    Askanase, Anca
    Kalunian, Kenneth
    Collins, Christopher
    Saxena, Amit
    Massarotti, Elena
    Alexander, Roberta
    Ibarra, Claudia
    O'Malley, Tyler
    Conklin, John
    Ramsey-Goldman, Rosalind
    Ahearn, Joseph
    Manzi, Susan
    Weinstein, Arthur
    Dervieux, Thierry
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [27] New approach to prevent complement activation on xenografts: Effects of a surface-bound form of human C4b binding protein
    Mikata, S
    Miyagawa, S
    Kamiike, W
    Ito, T
    Matsuda, H
    Iwata, K
    Nagasawa, S
    Seya, T
    Shirakura, R
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (01) : 65 - 66
  • [28] Human T cell derived, cell-bound complement iC3b is integrally involved in T cell activation
    Torok, Katalin
    Kremlitzka, Mariann
    Sandor, Noemi
    Toth, Eszter Angela
    Bajtay, Zsuzsa
    Erdei, Anna
    IMMUNOLOGY LETTERS, 2012, 143 (01) : 131 - 136
  • [29] HUMAN ALTERNATIVE COMPLEMENT PATHWAY - MEMBRANE-ASSOCIATED SIALIC-ACID REGULATES THE COMPETITION BETWEEN B AND BETA-1H FOR CELL-BOUND C3B
    KAZATCHKINE, MD
    FEARON, DT
    AUSTEN, KF
    JOURNAL OF IMMUNOLOGY, 1979, 122 (01): : 75 - 81
  • [30] EVIDENCE THAT A NICKED C4B, C4B', IS A FUNCTIONALLY ACTIVE C4B DERIVATIVE
    YAMAZAKI, M
    ICHIHARA, C
    NAGASAWA, S
    FEBS LETTERS, 1986, 208 (01) : 147 - 150